Pluri Inc (PLUR) Live Share Price, Invest From India

Pluri Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

Day's Low
Day's High
$3.01
Day's Price Range
$3.10
$3.07
1.95%
Downside
0.98%
Upside
52 Week's Low
52 Week's High
$2.82
52-Week Price Range
$7.13
$3.07
8.14%
Downside
132.25%
Upside

Pluri Inc share price movements today

Previous Close: $3.06
Open: $3.01
Volume: 147.0K
Day's Low - High: $3.01 - $3.10
52 Week Low - High: $2.82 - $7.13

Pluri Inc Historical Returns

1 Month Return: -16.62 %
3 Month Return: -4.67 %
1 Year Return: -32 %
3 Year Return: -57.14 %
5 Year Return: 0 %

Pluri Inc Stock Fundamentals & Key Indicators

Check Pluri Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$34.1M

EPS (TTM)

-2.7

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-21.9M

Revenue (TTM)

1.3M

Profit Margin

0.00%

Return On Equity TTM

-1021.98%

Pluri Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pluri Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pluri Inc	BUY	$34.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.4B	126.75%	133.41	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.3B	112.49%	29.68	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.5B	58.91%	17.67	31.41%

Stock Returns calculator for Pluri Inc Stock including INR - Dollar returns

The Pluri Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pluri Inc investment value today

Current value as on today

₹77,763

Returns

₹22,237

(-22.24%)

Returns from Pluri Inc Stock

₹31,778 (-31.78%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Pluri Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Pluri Inc. Average target price of $12

Pluri Inc Share Price Target

Get share price movements and forecasts by analysts on Pluri Inc.

What analysts predicted

74.42%UPSIDE

Target Price

$12

Current Price

$3.07

Analyzed by

7 Analysts

Target

$12.00

Pluri Inc target price $12, a slight upside of 74.42% compared to current price of $3.07. According to 7 analysts rating.

Pluri Inc Stock’s Investor Sentiment and Interest

Search interest for Pluri Inc Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 23, 2026 to March 25, 2026

Change:-8% versus previous 30 day period

Pluri Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-5	-5	-6	-5	-4	-5	-6	-6	-6
EBITDA	-4	-4	-5	-5	-5	-2	-6	-7	-6	-6
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-4	-5	-5	-6	-3	-6	-7	-6	-6
Income Tax Expense	0	0	0	0	-	-	-	0	0	0
Net Income	-4	-4	-5	-5	-5	-2	-6	-7	-5	-6
Net Profit Margin	-9187.04%	-4671.43%	-7454.93%	-5967.71%	-1804.29%	-1597.84%	-1439.58%	-1909.05%	-1851.27%	-3304.55%

Pluri Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	2	0	0	0	-	0	0	0	1
Gross Profit	2	0	0	-1	-1	0	0	0	0
Operating Income	-23	-33	-35	-29	-50	-41	-27	-22	-22
EBITDA	-21	-24	-33	-27	-48	-39	-27	-20	-22
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	-	-	1	1	1	1	0	0	0
Income Before Tax	-23	-26	-35	-29	-49	-41	-28	-21	-23
Income Tax Expense	0	7	0	0	0	0	0	0	0
Net Income	-23	-26	-35	-29	-49	-41	-28	-20	-22
Net Profit Margin	-816.51%	-52252.00%	-65383.33%	-126747.83%	0.00%	-17624.79%	-9867.94%	-6407.36%	-1690.34%

Pluri Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-4	-5	-5	-6	-3	-6	-7	-6	-6
Operating Cash Flow	-3	-4	-4	-4	-4	-4	-5	-5	-5
Investing Cash Flow	3	5	-4	0	8	-4	3	3	2
Financing Cash Flow	-	-	8	-	-7	9	0	-	2
Change in Cash	0	1	0	-3	4	1	-2	-1	0

Pluri Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-27	-26	-35	-29	-49	-41	-28	-21	-23
Operating Cash Flow	-21	-21	-29	-26	-30	-36	-22	-18	-18
Investing Cash Flow	4	5	1	-30	-7	11	9	10	8
Financing Cash Flow	15	19	23	60	61	7	8	8	9
Change in Cash	-1	4	-4	4	22	-20	-5	1	0

Global Institutional Holdings in Pluri Inc

Funds	Holdings
Royal Bank of Canada	0%
SBI Securities Co Ltd	0%
UBS Group AG	0%
Huntington National Bank	0%
IFP Advisors, LLC	0%

See all

Insights on Pluri Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 48.1%
NO EFFECT
Against Peers
In the last 3 years, Pluri Inc has experienced a drawdown of -57.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 46.9%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 427.0K → 198.0K (in $), with an average decrease of 21.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, PLUR stock has moved down by -7.0%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -5.85M → -6.54M (in $), with an average decrease of 11.9% per quarter

About Pluri Inc

pluristem therapeutics inc. (nasdaqcm: psti, tase: psti/pltr) is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3d) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation. pluristem’s placental expanded (plx) cells are placenta-derived, mesenchymal-like adherent stromal cells that are designed to be administered to patients without the need for tissue or genetic matching. these cells release soluble biomolecules, such as cytokines, chemokines and growth factors, which act in a paracrine or endocrine manner to facilitate healing of damaged tissues by stimulating the body’s own regenerative mechanisms. the company’s proprietary, 3d expansion technology can be used to grow plx cells in mass quantities with batch-to-batch consistency at pluristem’s fda, ema and pmda-approved, state-of-the art manufacturing facility. pluristem’s first product candi

Organisation	Pluri Inc
Headquarters	MATAM Advanced Technology Park, Haifa, Israel, 3508409
CEO	Mr. Yaacov Yanay
E-voting on shares	Click here to vote

Key Management of Pluri Inc

Name	Title
Mr. Ori Shalem	Vice President of Operations & Manufacturing
Dr. Arthur Machlenkin Ph.D.	Chief Scientific Officer
Ms. Nofar Glaich-Dabach	Vice President of Human Resources
Ms. Efrat Kaduri	Chief Business Development Officer of Pharma
Mr. Nimrod Bar Zvi	Chief Commercial Officer
Mr. Yaacov Yanay	President, CEO & Director
Mr. Lior Raviv	Chief Technology Officer
Ms. Hagit Gal	General Counsel
Ms. Orly Amiran	Chief Quality Officer
Ms. Liat Zalts	CFO & Treasurer

FAQs

What is Pluri Inc share price today?

Pluri Inc share price today is $3.07 as on March 25, 2026 at 1:29 am IST at the close of the market. Pluri Inc share today touched a day high of $3.1 and a low of $3.01.

What is the 52 week high and 52 week low for Pluri Inc share?

Pluri Inc share touched a 52 week high of $7.13 on April 23, 2025 and a 52 week low of $2.82 on December 17, 2025. Pluri Inc stock price today i.e. March 25, 2026 at 1:29 am IST is closed at $3.07,which is 56.94% down from its 52 week high and 8.87% up from its 52 week low.

What is Pluri Inc's market capitalisation today?

Pluri Inc market capitalisation is $0.00T as on March 25, 2026 at 1:29 am IST.

How to invest in Pluri Inc Stock (PLUR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pluri Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pluri Inc Shares that will get you 0.4886 shares as per Pluri Inc share price of $3.07 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Pluri Inc Stock (PLUR) from India?

Indian investors can start investing in Pluri Inc (PLUR) shares with as little as ₹93.734 or $1 (as of March 25, 2026 at 6:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Pluri Inc stock (as per the Rupee-Dollar exchange rate as on March 25, 2026 at 6:44 am IST). Based on Pluri Inc share’s latest price of $3.07 as on March 25, 2026 at 1:29 am IST, you will get 3.2573 shares of Pluri Inc. Learn more about fractional shares .